Literature DB >> 34497864

Effect of COVID-19 on Ulnar Collateral Ligament Reconstruction in Major League Baseball Pitchers.

Ryan W Paul1, Ali Omari1, Brian Fliegel2, Meghan E Bishop1, Brandon J Erickson1, Frank G Alberta1,3,4.   

Abstract

BACKGROUND: The coronavirus disease of 2019 (COVID-19) pandemic led to the suspension and shortening of the 2020 Major League Baseball (MLB) season from 162 to 60 regular season games. The effect of this disruption on injury rates, specifically injury to the ulnar collateral ligament (UCL), has not been quantified. PURPOSE/HYPOTHESIS: The purpose of this study was to compare the rate of UCL reconstruction (UCLR), surgery timing, and pitching workload in MLB pitchers from before and after the COVID-19 pandemic lockdown. We hypothesized that UCLR rates relative to games played would be increased and pitching workload would be decreased in 2020 compared with previous seasons. STUDY
DESIGN: Cohort study; Level of evidence, 3.
METHODS: An extensive online search using publicly available data was conducted to identify all MLB pitchers who underwent UCLR between January 1, 2017, and December 31, 2020. Only pitchers who were competing at the MLB level when undergoing reconstruction were included. Player characteristics and surgery date, as well as career and season of surgery pitching workload, were collected for all included pitchers. All data were compared as a pooled sample (2017-2019 vs 2020).
RESULTS: A similar number of pitchers underwent UCLR during or after the 2020 regular season (n = 18) compared with the 2017-2019 seasons (n = 16, 20, and 16, respectively). However, after accounting for the decrease in games played during the 2020 regular season, an MLB pitcher was 2.9 times more likely to undergo surgery per game after the COVID-19 lockdown compared with the previous years (P < .001). MLB pitchers who underwent surgery in 2020 threw fewer preseason innings than did pitchers who underwent surgery between 2017 and 2019 (5.98 vs 9.39; P = .001).
CONCLUSION: MLB pitchers were almost 3 times more likely to undergo UCLR per game after the COVID-19 lockdown. A decreased preseason pitching workload because of the COVID-19 lockdown may have had an effect on per game UCLR rates.
© The Author(s) 2021.

Entities:  

Keywords:  COVID-19; MLB; reconstruction; ulnar collateral ligament

Year:  2021        PMID: 34497864      PMCID: PMC8419557          DOI: 10.1177/23259671211041359

Source DB:  PubMed          Journal:  Orthop J Sports Med        ISSN: 2325-9671


  44 in total

1.  Risk factors for shoulder and elbow injuries in adolescent baseball pitchers.

Authors:  Samuel J Olsen; Glenn S Fleisig; Shouchen Dun; Jeremy Loftice; James R Andrews
Journal:  Am J Sports Med       Date:  2006-02-01       Impact factor: 6.202

2.  End range eccentric antagonist/concentric agonist strength ratios: a new perspective in shoulder strength assessment.

Authors:  C R Scoville; R A Arciero; D C Taylor; P D Stoneman
Journal:  J Orthop Sports Phys Ther       Date:  1997-03       Impact factor: 4.751

3.  Injury Trends in Major League Baseball Over 18 Seasons: 1998-2015.

Authors:  Stan Conte; Christopher L Camp; Joshua S Dines
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2016 Mar-Apr

4.  Predictors of Ulnar Collateral Ligament Reconstruction in Major League Baseball Pitchers.

Authors:  David Whiteside; Douglas N Martini; Adam S Lepley; Ronald F Zernicke; Grant C Goulet
Journal:  Am J Sports Med       Date:  2016-05-06       Impact factor: 6.202

Review 5.  The success of return to sport after ulnar collateral ligament injury in baseball: a systematic review and meta-analysis.

Authors:  Scott D Peters; Garrett S Bullock; Adam P Goode; Grant E Garrigues; David S Ruch; Michael P Reiman
Journal:  J Shoulder Elbow Surg       Date:  2018-03       Impact factor: 3.019

6.  Nonoperative Treatment of Elbow Ulnar Collateral Ligament Injuries With and Without Platelet-Rich Plasma in Professional Baseball Players: A Comparative and Matched Cohort Analysis.

Authors:  Aakash Chauhan; Peter McQueen; Peter N Chalmers; Michael G Ciccotti; Christopher L Camp; John D'Angelo; Hollis G Potter; Stephen A Fealy; Brandon J Erickson; Heinz R Hoenecke; Daniel Keefe; Julie McCauley; Jan Fronek
Journal:  Am J Sports Med       Date:  2019-10-07       Impact factor: 6.202

7.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.

Authors:  Maximilian Ackermann; Stijn E Verleden; Mark Kuehnel; Axel Haverich; Tobias Welte; Florian Laenger; Arno Vanstapel; Christopher Werlein; Helge Stark; Alexandar Tzankov; William W Li; Vincent W Li; Steven J Mentzer; Danny Jonigk
Journal:  N Engl J Med       Date:  2020-05-21       Impact factor: 91.245

8.  When can professional sport recommence safely during the COVID-19 pandemic? Risk assessment and factors to consider.

Authors:  Sean Carmody; Andrew Murray; Mariya Borodina; Vincent Gouttebarge; Andrew Massey
Journal:  Br J Sports Med       Date:  2020-05-07       Impact factor: 13.800

9.  Is Tommy John Surgery Performed More Frequently in Major League Baseball Pitchers From Warm Weather Areas?

Authors:  Brandon J Erickson; Joshua D Harris; Matthew Tetreault; Charles Bush-Joseph; Mark Cohen; Anthony A Romeo
Journal:  Orthop J Sports Med       Date:  2014-10-27

Review 10.  Cardiovascular disease and COVID-19.

Authors:  Manish Bansal
Journal:  Diabetes Metab Syndr       Date:  2020-03-25
View more
  2 in total

1.  Injury Incidence Increases after COVID-19 Infection: A Case Study with a Male Professional Football Team.

Authors:  Antonio Maestro; David Varillas-Delgado; Esther Morencos; Jorge Gutiérrez-Hellín; Millán Aguilar-Navarro; Gonzalo Revuelta; Juan Del Coso
Journal:  Int J Environ Res Public Health       Date:  2022-08-18       Impact factor: 4.614

2.  Lifestyle Changes and Baseball Activity among Youth Baseball Players before and during the First COVID-19 Pandemic in Japan.

Authors:  Ryota Kuratsubo; Masashi Kawabata; Emi Nakamura; Masumi Yoshimoto; Satoshi Tsunoda; Yuji Takazawa; Hiroyuki Watanabe
Journal:  Children (Basel)       Date:  2022-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.